Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
BRAIN
Publication-derived

Hindbrain Organoids for Disease Modelling

Source Anderle · CIBIO-University of Trento · DOI

Duration: 120 days Cell source: Human iPSC Full SOP · 8 phases · QC included
Disease modelling
Full SOP with Academic or a plan
LIVER
Publication-derived

Fatty Liver Disease Organoids for Infection Studies (LV-FI-18)

Source Sendi et al., 2018 · Wake Forest Institute of Regenerative Medicine / Wake Forest Baptist Medical Center · DOI

Duration: 28 days Cell source: Primary Human Hepatocytes, Kupffer Cells, Hepatic Stellate Cells, Liver Sinusoidal Endothelial Cells Full SOP · 8 phases · QC included
Disease modelling
LV-FI-18 Full SOP with Academic or a plan
BREAST
Publication-derived

Breast Cancer Tumouroids for Biobanking (BR-DS-18)

Source Sachs et al., 2018 · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht · DOI

Duration: 14 days Cell source: Human primary and metastatic breast cancer tissue Full SOP · 12 phases · QC included
Drug screening
BR-DS-18 Full SOP with Academic or a plan
BRAIN
Publication-derived

Neonatal Herpes Encephalitis Brain Organoids (BN-DS-22)

Source D'Aiuto et al., 2022 · Western Psychiatric Institute and Clinic, Department of Psychiatry, School of Medicine, University of Pittsburgh · DOI

Duration: 35 days Cell source: Human iPSC Full SOP · 12 phases · QC included
Disease modelling
BN-DS-22 Full SOP with Academic or a plan
BRAIN
Publication-derived

Medulloblastoma Hindbrain Organoids (BN-DS-25)

Source Willott et al., 2025 · Brain Tumour Research Centre, Blizard Institute, Queen Mary University of London · DOI

Duration: 53 days Cell source: Human EPSC (from dura mater fibroblasts) Full SOP · 9 phases · QC included
Drug screening
BN-DS-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organoids for Drug Screening and Development (BN-DS-16)

Source Kelava et al., 2016 · MRC Laboratory of Molecular Biology, Cambridge · DOI

Duration: 100 days Cell source: Human ESC, Human iPSC Full SOP · 5 phases · QC included
Drug screening
BN-DS-16 Full SOP with Academic or a plan
LIVER
Publication-derived

Alcohol-Induced Liver Injury Organ-on-Chip Models (LV-DI-25)

Source Yang et al., 2025 · Shanghai University of Traditional Chinese Medicine · DOI

Duration: 26 days Cell source: Human reprogrammed hepatocyte-like cells (hrHL) co-cultured with HUVECs and HUMSCs Full SOP · 14 phases · QC included
Drug screening
LV-DI-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organ-on-Chip Models for Disease Modelling (BN-DS-21)

Source Ao et al., 2021 · Indiana University · DOI

Duration: 42 days Cell source: Human ESC (WA01) Full SOP · 12 phases · QC included
Disease modelling
BN-DS-21 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Organoids for Regenerative Medicine with Cryopreservation (RT-DS-17)

Source Reichman et al., 2017 · Institut de la Vision, Sorbonne Universités, INSERM, CNRS, UPMC, Paris, France · DOI

Duration: 100 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Disease modelling
RT-DS-17 Full SOP with Academic or a plan
SKIN
Publication-derived

Epidermal Organoids for Regeneration and Disease Modelling (SK-DS-19)

Source Kim et al., 2019 · CiSTEM Laboratory, Catholic Induced Pluripotent Stem Cell (iPSC) Research Center, College of Medicine, The Catholic University of Korea · DOI

Duration: 30 days Cell source: Cord blood mononuclear cell-derived induced pluripotent stem cells (CBMC-iPSCs) Full SOP · 6 phases · QC included
Disease modelling
SK-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Meningioma Brain Organoids for Drug Screening (BN-CA-25)

Source Zohdy et al., 2025 · Emory University School of Medicine, Department of Neurosurgery · DOI

Duration: 45 days Cell source: Patient-Derived Tumor (Meningioma) Full SOP · 6 phases · QC included
Drug screening
BN-CA-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Zika Virus Infection Brain Organoids for Disease Modelling (BN-DS-16)

Source Garcez et al., 2016 · D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil · DOI

Duration: 46 days Cell source: Human iPSC-derived Neural Stem Cells (NSCs) Full SOP · 6 phases · QC included
Disease modelling
BN-DS-16 Full SOP with Academic or a plan
BRAIN
Publication-derived

Cryptococcal Meningoencephalitis Brain Organoids

Source Bennett et al. · University of California, Davis, Department of Pharmacology, School of Medicine · DOI

Duration: 30 days Cell source: Human immortalized brain endothelial cells (iBMEC/D3), primary human brain microvascular endothelial cells, human primary astrocytes, human primary brain vascular pericytes Full SOP · 8 phases · QC included
Disease modelling
Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organoids for Infection Studies (2016) (BN-DS-16)

Source Garcez et al., 2016 · D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil · DOI

Duration: 46 days Cell source: Human iPSC-derived neural stem cells (NSCs) Full SOP · 7 phases · QC included
Disease modelling
BN-DS-16 Full SOP with Academic or a plan
BRAIN
Publication-derived

Alzheimer's Disease Cortical Organoids (BN-DS-24)

Source Kawatani et al., 2024 · Mayo Clinic, Jacksonville, FL · DOI

Duration: 60 days Cell source: Human iPSC Full SOP · 12 phases · QC included
Disease modelling
BN-DS-24 Full SOP with Academic or a plan
OTHER
Publication-derived

Tumouroids for Drug Screening and Disease Modelling

Source Fusco et al., 2019 · Fondazione Istituto di Ricerca Pediatrica Città della Speranza (IRP) - Neuroblastoma Laboratory, Padova, Italy · DOI

Duration: 90 days Cell source: Patient-Derived iPSC (Neuroblastoma) Full SOP · 10 phases · QC included
Drug screening
Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Brain Organoids for Disease Modelling (BN-DS-20)

Source Ramani et al., 2020 · Institute of Human Genetics, University Hospital Düsseldorf, Heinrich-Heine-Universität · DOI

Duration: 60 days Cell source: Human iPSC Full SOP · 8 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
LIVER
Publication-derived

Fatty Liver Disease Organoids for Developmental Studies (LV-DS-25)

Source You et al., 2025 · Henan University of Science and Technology; Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences · DOI

Duration: 22 days Cell source: Human iPSC Full SOP · 14 phases · QC included
Drug screening
LV-DS-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Primary Progressive Multiple Sclerosis Cerebral Organoids (BN-DS-22)

Source Daviaud et al., 2022 · Tisch Multiple Sclerosis Research Center of New York · DOI

Duration: 42 days Cell source: Patient-Derived iPSC (Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis) and Healthy Control Full SOP · 6 phases · QC included
Disease modelling
BN-DS-22 Full SOP with Academic or a plan
KIDNEY
Publication-derived

Kidney Organoids for Disease Modelling with Vasculature (KD-DS-19)

Source Homan et al., 2019 · Wyss Institute for Biologically Inspired Engineering, Harvard University; Renal Division, Brigham and Women's Hospital · DOI

Duration: 21 days Cell source: Human iPSC (BJFF line) and Human ESC (H9) Full SOP · 5 phases · QC included
Disease modelling
KD-DS-19 Full SOP with Academic or a plan
LIVER
Publication-derived

Autosomal Recessive Polycystic Kidney Disease Liver Organoids (LV-FI-21)

Source Guan et al., 2021 · Stanford University, Department of Anesthesiology, Pain and Perioperative Medicine · DOI

Duration: 90 days Cell source: Human iPSC (Patient-Derived iPSC and Isogenic Controls) Full SOP · 9 phases · QC included
Disease modelling
LV-FI-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Cortical Organoids for Disease Modelling (2020) (BN-DS-20)

Source Qian et al., 2020 · Department of Neuroscience and Mahoney Institute for Neurosciences, University of Pennsylvania, Philadelphia, PA · DOI

Duration: 150 days Cell source: Human iPSC Full SOP · 2 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Organoids for Disease Modelling (IN-CA-15)

Source Matano et al., 2015 · Keio University School of Medicine, Tokyo, Japan · DOI

Duration: 240 days Cell source: Normal human intestinal epithelial cells from endoscopic biopsy samples Full SOP · 9 phases · QC included
Disease modelling
IN-CA-15 Full SOP with Academic or a plan
BRAIN
Publication-derived

Lyme Neuroborreliosis Brain Organoids (BN-DS-23)

Source Adams et al., 2023 · Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen · DOI

Duration: 9 days Cell source: Human iPSC-derived (hCMEC/D3 endothelial cells, primary astrocytes, pericytes) Full SOP · 6 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan